Whilst at Israel’s Weizmann Institute, molecular geneticist Professor Michel Revel developed treatments for MS, ALS and diabetes. Now at 75 years of age, he works at his biotech Kadimastem developing pluripotent stem cells as a regenerative medicine solution for all three diseases.
http://www.jpost.com/LandedPages/PrintArticle.aspx?id=342247